119 S 355
FDA Modernization Act 3.0
Latest Action
Held at the desk.
2025-12-17
Read the Bill
Primary sources on Congress.gov:
Cosponsors (showing 9 of 9)
R · Schmitt, Eric (Missouri)I · King, Angus S., Jr. (Maine)R · Kennedy, John (Louisiana)D · Whitehouse, Sheldon (Rhode Island)R · Marshall, Roger (Kansas)D · Blumenthal, Richard (Connecticut)R · Paul, Rand (Kentucky)D · Luján, Ben Ray (New Mexico)D · Schiff, Adam B. (California)Federal Agency Posts Matching This Bill
Posts from federal agencies in the last 24 hours that match this bill's identifier or title keywords. Grouped by voice class — executive framing carries the administration's perspective; regulators speak to implementation; oversight bodies aim for neutrality. Read across, not just within, a single voice class.
Independent oversight (CBO, GAO, Federal Register, Congress.gov)
Non-partisan analysis: CBO cost scoring, GAO investigations, Federal Register rule publications, and Congress.gov legislative tracking. The closest thing to neutral framing on a bill's likely effect.
CBO (fiscal scoring)
oversight
Thu, 10 Se
H.R. 9342, GPO Modernization Act of 2026
As ordered reported by the House Committee on House Administration on June 24, 2026
Read on cbo.gov →Markets vs Bill
No directly-mapped prediction markets indexed yet for this bill's policy domain.
Cite this page
APA
Apprised.news. (n.d.). 119 S 355: FDA Modernization Act 3.0. Retrieved 2026-09-11, from https://apprised.news/bill/119s355
MLA
"119 S 355: FDA Modernization Act 3.0." Apprised.news. Web. 2026-09-11. <https://apprised.news/bill/119s355>.
Chicago
"119 S 355: FDA Modernization Act 3.0." Apprised.news. Accessed 2026-09-11. https://apprised.news/bill/119s355.
BibTeX
@misc{apprised_119_s_355_fda_modernization_act_3_0,
title = {119 S 355: FDA Modernization Act 3.0},
publisher = {Apprised.news},
url = {https://apprised.news/bill/119s355},
note = {Accessed 2026-09-11}
}